Articles published by Psycheceutical Bioscience, Inc.![]() ![]() ![]() ![]()
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
February 02, 2023
Via GlobeNewswire
Tickers
BWVI
![]() ![]()
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
January 10, 2023
Via GlobeNewswire
Tickers
BWVI
![]()
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
November 29, 2022
Via GlobeNewswire
Tickers
BWVI
![]()
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
October 18, 2022
Via GlobeNewswire
Tickers
BWVI
![]()
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
October 04, 2022
Via GlobeNewswire
Tickers
BWVI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.